Shandong's first batch of 40 varieties with volume procurement 5 categories of high-value consumables by the end of the year to complete the procurement

Text . . Fengqiu September 14, Shandong Provincial Standing Committee to consider the adoption of "Shandong Province drugs and high-value medical supplies centralized belt procurement implementation program", the recent Shandong Provincial Health Insurance Bureau will first carry out the province's first batch of drugs and high-value medical supplies centralized belt procurement, for the national drug market selected the first batch of 40 drug varieties, covering cardiovascular, digestion, respiratory, tumor and other clinical disciplines, is currently the largest number of provincial procurement of one-time centralized procurement of drugs.
, speed up the selection of 5 categories of high-value medical supplies centralized belt procurement varieties, by the end of the year to complete the procurement.
According to Qilu.com, the overall requirements of the Program are clear, give full play to the leading role of centralized belt procurement in deepening the supply-side reform of pharmaceutical services, and implement centralized belt procurement of medicines and high-value medical supplies in accordance with the requirements of "belt procurement, recruitment and collection, quality priority, ensuring the amount of money, ensuring return", strengthening process-wide supervision, guiding fair competition among pharmaceutical enterprises;
The procurement cycle is not less than one year, eligible enterprises may voluntarily participate in the centralized belt procurement, the Program clearly all public medical institutions in the province, military medical institutions in Lu to participate in drug and high-value medical supplies centralized belt procurement, encourage other medical institutions, retail pharmacies to actively participate in the procurement cycle of not less than one year.
range of varieties from the focus on the masses to reflect high prices, medical institutions, a wide range of patients with a wide audience of drugs and high-value medical supplies, and gradually expand.
In terms of the scope of production enterprises, the Program clearly approves by the drug regulatory authorities, drugs listed in Chinese mainland, high-value medical supplies production enterprises (drug market license holders and imported drugs, supplies, the national general agent as a production enterprise), can participate voluntarily.
the selected enterprise shall undertake to meet the agreed quantity supply demand during the period of the purchase agreement.
In terms of procurement form and quantity of procurement, the Program innovates the method of procurement, divides the evaluation groups of the reporting enterprises according to factors such as quality, efficacy differences and market recognition, conducts a comprehensive review of the evaluation groups of 3 or more reporting enterprises, and determines the results of the selection by bargaining.
Combined with the medical institutions related drugs, high-value medical supplies next year's planned procurement volume and the previous year's procurement data to determine the evaluation team agreed procurement volume calculation base, and in accordance with the proportion of not less than 50% of the calculation base to determine the agreed procurement volume.
Agreed that the amount of procurement shall not be less than 50% of the amount reported by medical institutions, and within 30 days to complete the payment in order to ensure the comprehensive results of price reduction, benefit people's livelihood and promote reform, the Program has formulated policies and measures for the implementation, use, settlement, quality and supply of selected medicines and medical supplies.
"Programme" requirements, medical institutions in accordance with the selected price, agreed procurement volume procurement, agreed procurement volume is not less than 50% of the amount reported by medical institutions.
the inefficient practice of signing contracts between pharmaceutical institutions and pharmaceutical enterprises respectively, and the municipal procurement federations shall sign contracts with pharmaceutical companies for the purchase and sale of quantities.
"Programme" provides for the centralized procurement of medicines and medical supplies to implement the medical insurance fund and pharmaceutical enterprises direct settlement, within 30 days to complete the payment, fundamentally and completely solve the medical institutions in arrears of payment brought about by a series of problems.
"Programme" provides that the selected drug to the selected price as the standard of payment for medical insurance, the price is lower than or equal to the price selected in the same evaluation group of non-selected drugs, the actual price as the payment standard.
of non-selected drugs higher than the selected price, the proportion of individual out-of-payment increased by 10%, leading patients and medical institutions to choose the selected products.
In order to relieve the financial pressure of medical institutions and mobilize the enthusiasm of medical institutions, the Program clearly stipulates that before the realization of direct settlement, the medical insurance fund shall advance to medical institutions at a rate not less than 50% of the amount agreed in the contract of the selected varieties;